Unexpected Tumor Rupture in a Case of Treatment-naïve Neuroblastoma - A Mortality Experience from a Tertiary Medical Institution

A Mortality Experience from a Treatment-naïve Neuroblastoma


Abstract views: 102

Authors

  • Wan-Ju Lee Mackay Memorial Hospital, Clinic of Radiation Oncology, Taipei, Taiwan
  • Yi-Lun Wang Chang Gung Children’s Hospital, Clinic of Pediatrics, Divisions of Hematology and Oncology, Taoyuan, Taiwan https://orcid.org/0000-0002-0003-5153
  • Tsung-Yen Chang Chang Gung Children’s Hospital, Clinic of Pediatrics, Divisions of Hematology and Oncology, Taoyuan, Taiwan https://orcid.org/0000-0003-1123-4235

DOI:

https://doi.org/10.4274/jpea.2024.254

Keywords:

Mortality, neuroblastoma, oncology, pediatrics

Abstract

Neuroblastoma (NBL) is one of the most common extracranial neoplasms in children. Mortality is often attributed to treatment-related adverse events, sepsis secondary to immunocompromised status, and multi-organ failure resulting from advanced illness. Cases of NBL initially presenting with life-threatening events are rare. Here, we present a fatal NBL case that initially manifested profound anemia and coagulopathy, which later progressed to hemorrhagic shock due to tumor rupture.

Downloads

Published

2024-02-13

How to Cite

Lee, W.-J., Wang, Y.-L., & Chang, T.-Y. (2024). Unexpected Tumor Rupture in a Case of Treatment-naïve Neuroblastoma - A Mortality Experience from a Tertiary Medical Institution: A Mortality Experience from a Treatment-naïve Neuroblastoma. The Journal of Pediatric Academy, 5(1), 34–36. https://doi.org/10.4274/jpea.2024.254